These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23786877)
1. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival. Yang Y; Hong Q; Shi P; Liu Z; Luo J; Shao Z Breast Cancer Res; 2013 Jun; 15(3):R50. PubMed ID: 23786877 [TBL] [Abstract][Full Text] [Related]
2. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972 [TBL] [Abstract][Full Text] [Related]
3. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis. Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365 [TBL] [Abstract][Full Text] [Related]
4. Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis. Luo P; Yang X; Huang S; Feng S; Ou Z BMC Cancer; 2020 Feb; 20(1):159. PubMed ID: 32106836 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
6. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128 [TBL] [Abstract][Full Text] [Related]
7. MDA-9/syntenin is a key regulator of glioma pathogenesis. Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713 [TBL] [Abstract][Full Text] [Related]
8. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664 [TBL] [Abstract][Full Text] [Related]
9. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]. Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis. Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103 [TBL] [Abstract][Full Text] [Related]
11. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458 [TBL] [Abstract][Full Text] [Related]
12. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer. Liao YM; Wang YH; Hung JT; Lin YJ; Huang YL; Liao GS; Hsu YL; Wu JC; Yu AL Breast Cancer Res; 2021 Jan; 23(1):5. PubMed ID: 33413566 [TBL] [Abstract][Full Text] [Related]
13. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma. Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K Med Oncol; 2013; 30(3):615. PubMed ID: 23729267 [TBL] [Abstract][Full Text] [Related]
15. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. Zhang W; Hou T; Niu C; Song L; Zhang Y PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043 [TBL] [Abstract][Full Text] [Related]
17. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin. Tian W; Wu W; Li X; Rui X; Wu Y Biochem Biophys Res Commun; 2019 Jan; 508(1):295-301. PubMed ID: 30502089 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751 [TBL] [Abstract][Full Text] [Related]
20. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]